Response assessment to venetoclax in relapsed/refractory chronic lymphocytic leukemia by ultrasonography
E. Benedetti(University of Illinois Chicago), Sara Galimberti(University of Pisa), Benedetto Bruno(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Emilia Bramanti(Institute for the Chemistry of OrganoMetallic Compounds), Lydia Scarfò(IRCCS Ospedale San Raffaele), Claudia Baratè(Azienda Ospedaliera Universitaria Pisana), Paolo Ghia(Vita-Salute San Raffaele University), Riccardo Morganti(Azienda Ospedaliera Universitaria Pisana), Vittorio Ricchiuto(Azienda Ospedaliera Universitaria Pisana)
Cited by 3
Related Papers
Isolated Single-Cycle Attosecond Pulses
|Science|2006|1.7k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|890